Early stage IT and Healthcare Investing

Salmedix

portfoliocompanies

company snapshot

salmedix

Salmedix was a start-up biotechnology firm focused on discovering and developing minimally-toxic therapies to treat cancers, particularly those that affect the growing global geriatric population. The company was acquired by Cephalon in May 2005.

website
www.cephalon.com
Leadership
Follow The Company
Investment Team
Facebook Google+ Twitter Email LinkedIn Share